Search

Your search keyword '"Ungar, Bella"' showing total 225 results

Search Constraints

Start Over You searched for: Author "Ungar, Bella" Remove constraint Author: "Ungar, Bella" Publication Type Academic Journals Remove constraint Publication Type: Academic Journals
225 results on '"Ungar, Bella"'

Search Results

2. Higher Adalimumab Concentration is Associated with Complete Fistula Healing in Patients with Perianal Fistulizing Crohn’s Disease

3. I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel Disease

5. Pan-Enteric Crohn's Capsule [Eliakim] Score Reliability and Responsiveness to Change in Active Crohn's Disease.

10. Prospective Observational Evaluation of the Time-Dependency of Adalimumab Immunogenicity and Drug Concentration in Ulcerative Colitis Patients: the POETIC II Study.

17. Prospective Observational Evaluation of Time-Dependency of Adalimumab Immunogenicity and Drug Concentrations: The POETIC Study

18. Discontinuation of Infliximab in Patients With Ulcerative Colitis Is Associated With Increased Risk of Relapse: A Multinational Retrospective Cohort Study

21. Computer-Aided Imaging Analysis of Probe-Based Confocal Laser Endomicroscopy With Molecular Labeling and Gene Expression Identifies Markers of Response to Biological Therapy in IBD Patients: The Endo-Omics Study.

24. Effectiveness and Safety of Vedolizumab in Anti-TNF-Naïve Patients With Inflammatory Bowel Disease—A Multicenter Retrospective European Study

27. Real‐world experience with Curcumin–QingDai combination for patients with active ulcerative colitis: A retrospective multicentre cohort study.

28. Outcome of inflammatory bowel disease patients with prior malignancy.

30. Do Vedolizumab trough Levels Predict the Outcome of Subsequent Therapy in Inflammatory Bowel Disease?

32. Efficacy and Safety of Vedolizumab for Induction of Remission in Inflammatory Bowel Disease—the Israeli Real-World Experience

35. Su1803 HIGHER MAINTENANCE ADALIMUMAB CONCENTRATION IS ASSOCIATED WITH COMPLETE FISTULA HEALING IN PATIENTS WITH PERIANAL FISTULIZING CROHN'S DISEASE

37. Ustekinumab and vedolizumab for extraintestinal manifestations in inflammatory bowel disease - a retrospective study.

38. Host transcriptome signatures in human faecal-washes predict histological remission in patients with IBD.

40. Signs and Symptoms of Acute Bowel Inflammation and the Risk of Progression to Inflammatory Bowel Disease: A Retrospective Analysis.

42. Differential Serum-intestinal Dynamics of Infliximab and Adalimumab in Inflammatory Bowel Disease Patients.

43. Acute Chest Pain as an Infusion Reaction to Vedolizumab.

44. Delaying an infliximab infusion by more than 3 days is associated with a significant reduction in trough levels but not with clinical worsening.

45. Risk of consecutive immunogenic failure in switchers of anti-tumor necrosis factor alpha among patients with inflammatory bowel diseases.

47. Machine learning for prediction of intra-abdominal abscesses in patients with Crohn's disease visiting the emergency department.

48. Dose optimisation for Loss of Response to Vedolizumab— Pharmacokinetics and Immune Mechanisms.

Catalog

Books, media, physical & digital resources